Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
6.78
Dollar change
+0.36
Percentage change
5.61
%
IndexRUT P/E- EPS (ttm)-6.79 Insider Own2.69% Shs Outstand156.35M Perf Week2.26%
Market Cap1.08B Forward P/E9.14 EPS next Y0.74 Insider Trans-6.07% Shs Float154.68M Perf Month-15.88%
Income-1052.12M PEG- EPS next Q0.16 Inst Own110.18% Short Float12.98% Perf Quarter-55.22%
Sales413.55M P/S2.61 EPS this Y106.82% Inst Trans-3.20% Short Ratio4.60 Perf Half Y-30.67%
Book/sh-2.08 P/B- EPS next Y68.56% ROA-132.00% Short Interest20.08M Perf Year-35.24%
Cash/sh0.76 P/C8.87 EPS next 5Y- ROE-559.14% 52W Range6.21 - 15.70 Perf YTD-40.73%
Dividend Est.- P/FCF7.29 EPS past 5Y-28.37% ROI-670.29% 52W High-56.82% Beta0.52
Dividend TTM- Quick Ratio0.82 Sales past 5Y5.56% Gross Margin99.56% 52W Low9.18% ATR (14)0.38
Dividend Ex-Date- Current Ratio0.82 EPS Y/Y TTM-671.31% Oper. Margin30.18% RSI (14)36.92 Volatility4.37% 4.89%
Employees267 Debt/Eq- Sales Y/Y TTM-0.86% Profit Margin-254.41% Recom1.17 Target Price16.33
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-110.53% Payout- Rel Volume0.53 Prev Close6.42
Sales Surprise-29.19% EPS Surprise-114.85% Sales Q/Q-28.05% EarningsMay 09 BMO Avg Volume4.37M Price6.78
SMA20-9.65% SMA50-15.38% SMA200-32.71% Trades Volume2,315,775 Change5.61%
Date Action Analyst Rating Change Price Target Change
Jan-17-24Initiated Craig Hallum Buy $21
Dec-14-23Initiated Wells Fargo Overweight $20
Nov-09-23Initiated Jefferies Buy $21
Sep-28-23Initiated JMP Securities Mkt Outperform $22
Sep-02-22Initiated CapitalOne Overweight $15
Apr-22-22Initiated Piper Sandler Overweight $16
Sep-30-20Downgrade Wells Fargo Overweight → Equal Weight $14 → $9
Jun-17-20Initiated Northland Capital Outperform $14
Jul-10-19Resumed Credit Suisse Neutral
Mar-27-19Upgrade Morgan Stanley Underweight → Equal-Weight
May-21-24 06:00AM
May-10-24 01:58PM
12:59PM
11:16AM
May-09-24 03:59PM
01:55PM Loading…
01:55PM
01:39PM
11:57AM
09:54AM
07:11AM
07:00AM
May-06-24 04:01PM
May-02-24 02:33PM
10:01AM
May-01-24 07:30AM
01:16PM Loading…
Apr-30-24 01:16PM
Apr-25-24 04:01PM
Apr-21-24 10:39AM
Mar-28-24 07:30AM
Mar-05-24 01:05PM
Feb-29-24 04:19PM
08:37AM
06:26AM
06:08AM
06:00AM
Feb-23-24 07:30AM
Feb-16-24 10:15AM
09:36AM
Feb-15-24 10:45PM
08:15AM
07:26AM Loading…
07:26AM
07:00AM
Feb-05-24 08:50AM
Feb-01-24 04:01PM
Jan-23-24 09:55AM
Jan-08-24 07:00PM
06:00AM
Jan-03-24 04:01PM
Dec-12-23 04:01PM
Nov-30-23 09:45AM
Nov-21-23 04:01PM
Nov-10-23 02:45PM
11:09AM
Nov-09-23 10:25PM
08:39AM
07:46AM
07:22AM
07:00AM
Oct-26-23 04:01PM
Oct-23-23 07:30AM
Oct-17-23 12:02PM
Oct-16-23 06:00AM
Oct-05-23 07:30AM
Oct-03-23 11:43AM
Oct-01-23 07:15AM
Sep-26-23 11:48AM
Sep-20-23 07:36AM
Sep-19-23 12:08PM
11:39AM
Sep-12-23 08:32AM
Sep-07-23 11:30AM
Aug-12-23 08:50AM
Aug-09-23 09:24AM
Aug-08-23 11:12PM
11:05AM
09:56AM
07:00AM
Jul-28-23 02:56PM
Jul-25-23 04:01PM
Jun-29-23 08:30AM
Jun-21-23 08:00PM
Jun-16-23 07:00AM
Jun-13-23 09:18AM
Jun-12-23 04:05PM
09:54AM
May-25-23 10:32AM
May-23-23 12:07PM
May-22-23 05:43PM
04:08PM
01:11PM
12:02PM
08:40AM
07:24AM
07:22AM
06:57AM
May-09-23 04:01PM
May-08-23 07:30AM
May-05-23 09:31AM
May-04-23 08:55AM
07:00AM
Apr-26-23 08:00PM
Apr-24-23 07:30AM
Apr-20-23 04:01PM
Mar-22-23 02:53PM
Mar-14-23 02:56AM
Mar-02-23 07:09AM
Feb-27-23 04:01PM
Feb-20-23 07:40AM
Feb-17-23 11:11AM
Feb-16-23 08:35AM
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shetzline MichaelCMO,SVP,Head-Res&DrugMar 08 '24Option Exercise0.0034,9360429,847Mar 12 04:05 PM
John MinardoChief Legal OfficerMar 08 '24Option Exercise0.0032,7520311,975Mar 12 04:05 PM
MCCOURT Thomas AChief Executive OfficerMar 08 '24Option Exercise0.00120,29801,217,948Mar 12 04:05 PM
Davis AndrewSVP, Chief Business OfficerMar 08 '24Option Exercise0.0037,1200310,756Mar 12 04:05 PM
Emany Sravan KumarSVP, Chief Financial OfficerMar 08 '24Option Exercise0.0037,1200338,853Mar 12 04:05 PM
Duane Jon RDirectorMar 06 '24Buy8.706,92060,204121,028Mar 08 04:05 PM
Emany Sravan KumarSVP, Chief Financial OfficerMar 04 '24Buy9.3810,684100,216301,733Mar 06 04:05 PM
MCCOURT Thomas AChief Executive OfficerFeb 12 '24Sale15.24177,1642,699,979832,774Feb 14 08:35 PM
John MinardoChief Legal OfficerFeb 12 '24Sale15.2447,380722,071224,796Feb 14 09:01 PM
Shetzline MichaelCMO,SVP,Head-Res&DrugFeb 12 '24Sale15.2438,618588,538340,484Feb 14 08:53 PM
Davis AndrewSVP, Chief Business OfficerFeb 12 '24Sale15.249,846150,053208,324Feb 14 08:42 PM
Silver RonaldPrincipal Accounting OfficerFeb 12 '24Sale15.247,908120,518134,264Feb 14 08:50 PM
Kessler Marla LDirectorDec 14 '23Sale11.199,926111,07296,572Dec 18 04:09 PM
Davis AndrewSVP, Chief Business OfficerNov 20 '23Sale9.693,28731,851217,374Nov 22 04:05 PM
Emany Sravan KumarSVP, Chief Financial OfficerSep 15 '23Buy8.3236,072300,119188,730Sep 18 05:07 PM
John MinardoChief Legal OfficerAug 14 '23Sale10.047,04570,732192,195Aug 16 04:20 PM
Silver RonaldPrincipal Accounting OfficerAug 14 '23Sale10.041,97619,839134,172Aug 16 04:21 PM
MCCOURT Thomas AChief Executive OfficerMay 30 '23Sale10.7026,632284,962758,284Jun 01 05:45 PM